Revenue and Profitability - The group's revenue increased from approximately HKD 15,131,000 for the nine months ended September 30, 2021, to approximately HKD 20,154,000 for the nine months ended September 30, 2022, representing an increase of about 33.3%[6] - The group's gross profit for the nine months ended September 30, 2022, was approximately HKD 1,101,000, with a gross profit margin of about 5.46%, compared to a gross profit of HKD 4,373,000 and a margin of 28.90% for the same period in 2021[6] - The total revenue for the nine months ended September 30, 2022, was HKD 20,154 thousand, compared to HKD 15,131 thousand in 2021, marking a 33.2% increase[27] - The reported segment profit for photography services was HKD 3,697,000, while medical services reported a loss of HKD 5,225,000, leading to an overall segment loss of HKD 765,000[30] - The service cost rose from approximately HKD 10,758,000 to approximately HKD 19,053,000, an increase of about 77% due to higher employee costs, physician fees, medical supplies, and depreciation[54] - Gross profit decreased from approximately HKD 4,373,000 to approximately HKD 1,101,000, with gross margin dropping from 28.90% to 5.46% due to increased service costs[55] Losses and Expenses - Loss attributable to equity shareholders increased from approximately HKD 4,467,000 for the nine months ended September 30, 2021, to approximately HKD 8,508,000 for the same period in 2022, primarily due to reduced gross profit and increased administrative expenses[6] - Administrative expenses rose to approximately HKD 12,591,000 for the nine months ended September 30, 2022, compared to HKD 9,972,000 for the same period in 2021, driven by increased employee costs and director remuneration[6] - Operating loss for the nine months ended September 30, 2022, was approximately HKD 8,909,000, compared to HKD 4,233,000 for the same period in 2021[14] - The group reported a net loss of approximately HKD 9,223,000 for the nine months ended September 30, 2022, compared to a net loss of HKD 4,484,000 for the same period in 2021[14] - Total comprehensive loss for the nine months ended September 30, 2022, was HKD (8,601) thousand, compared to HKD (4,587) thousand for the same period in 2021, representing a 87.5% increase in loss[15] Medical Services - Medical services revenue amounted to approximately HKD 4,794,000 for the nine months ended September 30, 2022, with no revenue reported for the same period in 2021, following the launch of medical services in Hong Kong[6] - The company continues to expand its service offerings by providing medical services through medical centers in Hong Kong since October 2021[19] - The medical services business was launched in October 2021, with the company actively seeking to expand by recruiting suitable medical professionals and acquiring necessary equipment[50] - The company plans to invest in upgrading medical equipment and software to enhance the quality and reliability of its medical services[50] Shareholder Information - The company does not recommend the declaration of any interim dividend for the nine months ended September 30, 2022[6] - The total comprehensive loss attributable to equity shareholders of the company was HKD (7,886) thousand for the nine months ended September 30, 2022, compared to HKD (4,570) thousand in 2021, reflecting a 72.5% increase[15] - The company’s major shareholders, Causeway Treasure, holds 427,600,560 shares, representing approximately 53.45% of the total issued shares[88] - Both Mr. Chen Yongji and Mr. Chen Tianqi own 427,600,560 shares in Causeway Treasure, each holding approximately 53.45% of the total issued shares[82] Operational Challenges and Future Outlook - The photography services revenue was weak due to the fifth wave of COVID-19 and travel restrictions, leading to a significant decline in demand for identity photos[45] - The company anticipates that the demand for identity photos in Hong Kong will recover in the near future as travel restrictions are lifted and vaccination rates increase[45] - The company has terminated leases for underperforming photo booth locations as a cost-control measure, reflecting a prudent approach to managing financial performance[48] - The economic impact of COVID-19 remains uncertain, and the company continues to monitor its effects on financial performance[48] - The company is taking a cautious approach to expanding its self-service photo booth business in Guangdong Province due to ongoing pandemic challenges[47] Financial Management and Governance - The company’s financial statements are prepared in accordance with Hong Kong Financial Reporting Standards, ensuring compliance with relevant regulations[21] - The company has established a remuneration committee to review the remuneration policies and structures for directors and senior management, with 56 employees as of September 30, 2022, compared to 37 employees a year earlier[66] - The company has established an audit committee in accordance with GEM listing rules to oversee financial reporting and risk management[96] - The audit committee reviewed the unaudited consolidated results for the nine months ended September 30, 2022, and found them compliant with applicable accounting standards and regulations[96] Investment and Funding - The company raised approximately HKD 62 million from the sale of 200,000,000 shares at HKD 0.31 per share, with a net amount of approximately HKD 31.85 million[98] - As of September 30, 2022, approximately HKD 14.53 million of the net proceeds had been utilized, with HKD 17.33 million remaining unutilized[99] - The company plans to allocate approximately HKD 17.9 million of the unutilized net proceeds to develop its medical services and related equipment, as well as to establish or acquire new clinics[101] - All unutilized proceeds have been deposited in a licensed bank in Hong Kong as of the report date[102] Compliance and Conduct - The company has adopted the GEM Listing Rules as its code of conduct for securities trading by directors, confirming compliance as of September 30, 2022[78] - The company has confirmed that there are no conflicts of interest among its directors as of September 30, 2022[93] - There are no undisclosed interests or positions held by directors or senior management in the company or its associated corporations as of September 30, 2022[86]
名仕快相(08483) - 2022 Q3 - 季度财报